Thalassemia Treatment with Bone Marrow Transplantation - Full Sibling Match | Beijing Jingdu Children's Hospital, China

9.60

Beijing, China

Overview

Age group

Kids

Type of care

Inpatient

Method

Non-surgical

About the offer

For children living with thalassemia, Beijing Jingdu Children’s Hospital provides specialized bone marrow transplantation services. The optimal transplant window is between 2 and 7 years of age—a golden period characterized by robust post-operative recovery and minimized surgical risks. Patients aged 8 to 18 are also eligible for the procedure. As a leading pediatric hematopoietic stem cell transplantation center with a track record of over 2,000 successful surgeries, we are at the forefront of adopting the proprietary Beijing Protocol for thalassemia treatment, offering new hope to young patients worldwide. Helmed by senior hematology specialists, our medical team further refines the Beijing Protocol to deliver fully personalized treatment plans. We particularly integrate umbilical cord blood transplantation-valued for its stable engraftment and low rejection risk-into our practice. This specialized, patient-centric approach has yielded an impressive 95. 6% success rate, underscoring our exceptional expertise in pediatric thalassemia treatment.

What’s included

Medical service

Examination

Comprehensive pediatric hematology consultation and physical examination
Detailed review of transfusion history, chelation adherence, infections, growth, and development
Pre-transplant fitness assessment with focused evaluation of cardiac, hepatic, endocrine, and nutritional status
Full sibling donor clinical assessment to confirm suitability for stem cell donation

Laboratory tests

Complete blood count (CBC) with reticulocyte count and peripheral smear
Iron overload workup: ferritin, iron studies, liver function tests
Infectious disease screening (patient and donor): Hepatitis B/C, HIV, CMV, EBV, syphilis as per protocol
Blood group typing, antibody screen, and extended RBC phenotyping
High-resolution HLA typing to confirm full sibling match
Baseline immune profile and chimerism planning tests (as indicated by protocol)
Renal profile, electrolytes, coagulation panel, glucose, and thyroid screening
Genetic confirmation of thalassemia mutation (if not previously documented)
Bone marrow evaluation when clinically indicated

Diagnosis

Confirmation of thalassemia type and severity (e.g., transfusion-dependent thalassemia)
Assessment of transfusion requirements, chelation history, alloimmunization, and infection risk
Evaluation of iron burden and organ involvement to determine transplant readiness
Verification of full sibling HLA match and donor eligibility

Treatment

Personalized allogeneic bone marrow transplantation plan using a full sibling donor
Pre-transplant optimization: iron chelation strategy, infection clearance, nutritional and organ support
Conditioning regimen selection based on age, disease status, and organ function
Bone marrow stem cell infusion with inpatient transplant monitoring and supportive care
GVHD prevention strategy and close monitoring for early complications
Post-transplant follow-up: engraftment tracking, immune recovery monitoring, and chimerism assessment
Supportive therapy as needed (antimicrobials, transfusions, electrolyte management, rehabilitation)
Structured discharge plan with long-term surveillance for late effects and quality-of-life recovery

Other

International patient coordination for scheduling, admission process, and document preparation
Upfront treatment plan summary, including expected duration of hospitalization (case-dependent)
Multidisciplinary case review (hematology, transplant team, infectious disease, nutrition)
Family education on transplant steps, infection prevention, medication management, and follow-up needs
Interpreter support and in-hospital guidance for visiting families

Distant service

Remote medical record review and pre-travel eligibility assessment for patient and sibling donor
Pre-arrival testing checklist and coordination to complete selected investigations locally
Online consultation to explain full sibling transplant benefits, risks, and expected outcomes
Post-treatment telemedicine follow-ups to review labs, medications, and recovery milestones
Coordination with the child’s local healthcare team for shared follow-up after returning home

Extra add-ons

Single room

Hospital meals

Personal coordinator

Language Assistance

Visa Support

AiroCare

AiroMedical support

Payment protection

Patient advocacy

Price match

Meet the provider

Beijing Jingdu Children's Hospital

Beijing, China

9.60

Gallery

Customize this offer

If you're not seeing exactly what you need here, send your custom request. You can discuss the content, specifics, price & timeline to create a personalized plan.

Location

308 Hui Long Guan Dong Da Jie, Chang Ping Qu, Bei Jing Shi, China, 102208

FAQ

What is the cost?

The total price for Thalassemia Treatment with Bone Marrow Transplantation - Full Sibling Match | Beijing Jingdu Children's Hospital, China is €36,869. However, it can vary from the specifics of each case. Get in touch to get an individual estimate.

What is the rating of the offer?

Thalassemia Treatment with Bone Marrow Transplantation - Full Sibling Match | Beijing Jingdu Children's Hospital, China is rated as 9.60 by AiroMedical.